(AGENPARL) – BRUXELLES mar 16 maggio 2023 This appraisal assesses two regulations for intellectual property rights applicable to the specific case of medicinal products and plant protection products – the Supplementary Protection Certificate Regulations (SPC Regulations for short). The analysis highlights the outcome of the European Commission’s assessment, discrepancies in implementation between Member States, and the complexity of striking a balance between various interests, since both regulations aim to reconcile public health imperatives, the need to foster research and development, and the interests of the pharmaceutical industry. The initiative may either put in place a unitary supplementary protection certificate and/or a single (‘unified’) procedure for granting national supplementary protection certificates. The objective is to make supplementary protection certificates more accessible and efficient for the health sector.
Fonte : © Unione europea, 2023 – PE
Fonte/Source: https://www.europarl.europa.eu/thinktank/it/document/EPRS_BRI(2023)740258